Sublingual Drug Candidate Improves Sleep Quality in Long COVID sleepreviewmag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sleepreviewmag.com Daily Mail and Mail on Sunday newspapers.
WASHINGTON — Once-daily etrasimod 1 mg and 2 mg was well-tolerated and sustained improvements in histological and endoscopic features of eosinophilic esophagitis, as well as patient symptoms, through 52 weeks of treatment, according to data.
“Etrasimod is a an oral, once-daily selective sphingosine 1-phosphate receptor modulator for the treatment of moderately to severely active
Study authors shared late-breaking data in a session on clinical trial results in pulmonary medicine at the American Thoracic Society 2024 International Conference.